Cleared Traditional

K962199 - QUANTEX C3 (FDA 510(k) Clearance)

Sep 1996
Decision
110d
Days
Class 2
Risk

K962199 is an FDA 510(k) clearance for the QUANTEX C3. This device is classified as a Complement C3, Antigen, Antiserum, Control (Class II - Special Controls, product code CZW).

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on September 25, 1996, 110 days after receiving the submission on June 7, 1996.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5240.

Submission Details

510(k) Number K962199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1996
Decision Date September 25, 1996
Days to Decision 110 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CZW — Complement C3, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5240